SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2

Meng Xu1, Huamao Jiang2, Haiguang Wang1

  • 1Department of Urology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, P.R. China.

Oncology Reports
|June 20, 2018
PubMed

Insights

SB225002, a CXCR2 antagonist, inhibits prostate cancer cell invasion by reducing SIBLINGs (small integrin-binding ligand N-linked glycoproteins) like BSP and OPN, and MMP-2 expression, particularly in androgen-independent cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Malignant cell metastasis is complex, involving small integrin-binding ligand N-linked glycoproteins (SIBLINGs) like bone sialoprotein (BSP) and osteopontin (OPN).
  • SIBLINGs enhance matrix metalloproteinase (MMP)-2 and MMP-9 expression, promoting cancer cell invasion and metastasis.
  • BSP and OPN interact with tumor cell surface integrins, further driving malignant behavior.

Purpose of the Study:

  • To investigate if SB225002, a CXCR2 receptor antagonist, can inhibit prostate cancer cell expression of BSP and OPN.
  • To determine if SB225002 can reduce prostate cancer cell invasion ability.
  • To explore the role of the PI3K signaling pathway in mediating these effects.

Main Methods:

  • Treatment of androgen-independent and androgen-dependent prostate cancer cell lines with SB225002.
  • Western blotting to analyze protein expression, including SIBLINGs, MMPs, and components of the PI3K/AKT/mTOR pathway.
  • In vivo experiments using mouse models to assess tumor growth and metastasis.

Main Results:

  • SB225002 inhibited proliferation, invasion, and migration of androgen-independent prostate cancer cells, but not androgen-dependent cells.
  • SB225002 reduced the expression of BSP, OPN, and MMP-2 in prostate cancer cells.
  • Inhibition of AKT/mTOR phosphorylation by SB225002 was linked to reduced SIBLING and MMP expression.
  • In vivo studies confirmed SB225002 inhibited prostate cancer cell proliferation and reduced BSP, OPN, and MMP-2 levels.

Conclusions:

  • SB225002 effectively inhibits the proliferation and invasion of androgen-independent prostate cancer cells.
  • The anti-metastatic effects of SB225002 are mediated through the inhibition of SIBLINGs (BSP, OPN) and MMP-2 expression via the PI3K/AKT/mTOR pathway.
  • CXCR2 receptor antagonism presents a potential therapeutic strategy for advanced prostate cancer.

Related Concept Videos

Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.5K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.2K
What is Gene Expression?01:42

What is Gene Expression?

Overview
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
196.9K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
26.5K